021-51111890
购物车（）
sales@molnova.cn
Ligustilide A
CAS No. 81944-09-4
Ligustilide A ( cis-Ligustilide )
产品货号. M24810 CAS No. 81944-09-4
Ligustilide A, an active ingredient isolated from the medicinal plants Angelica acutiloba and Cnidium officinale, inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥405 | 有现货 |
|
| 25MG | ￥591 | 有现货 |
|
| 50MG | ￥737 | 有现货 |
|
| 100MG | ￥1061 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ligustilide A
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Ligustilide A, an active ingredient isolated from the medicinal plants Angelica acutiloba and Cnidium officinale, inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation.
-
产品描述Ligustilide A, an active ingredient isolated from the medicinal plants Angelica acutiloba and Cnidium officinale, inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation.
-
同义词cis-Ligustilide
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体bacterial
-
研究领域——
-
适应症——
化学信息
-
CAS Number81944-09-4
-
分子量190.2
-
分子式C12H14O2
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL (525.65 mM; Need ultrasonic)
-
SMILESCCC/C=C\1/C2=C(C=CCC2)C(=O)O1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Wu Z, Uchi H, Morino-Koga S, Nakamura-Satomura A, Kita K, Shi W, Furue M. Z-Ligustilide inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation. Exp Dermatol. 2014 Apr;23(4):260-5. doi: 10.1111/exd.12360. PubMed PMID: 24588654.
产品手册
关联产品
-
Paromomycin Sulfate
Paromomycin Sulfate is an aminoglycoside antibiotics inhibiting protein synthesis in non-resistant cells by binding to 16S ribosomal RNA.
-
Tetrazole
Tetrazole is the bioisoster of carboxylic acid, possess considerable antibacterial property.
-
CRS-3123
A novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria as a novel agent to treat Clostridium difficile infection (CDI).
